Related references
Note: Only part of the references are listed.Metabotropic Glutamate Receptor 5 Upregulation in Children with Autism is Associated with Underexpression of Both Fragile X Mental Retardation Protein and GABAA Receptor Beta 3 in Adults with Autism
S. Hossein Fatemi et al.
ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY (2011)
Psychopharmacology of Autistic Spectrum Disorders in Children and Adolescents
Ahsan Nazeer
PEDIATRIC CLINICS OF NORTH AMERICA (2011)
A Systematic Review of Medical Treatments for Children With Autism Spectrum Disorders
Melissa L. McPheeters et al.
PEDIATRICS (2011)
Increased Gene Dosage of Ube3a Results in Autism Traits and Decreased Glutamate Synaptic Transmission in Mice
Stephen E. P. Smith et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Understanding and Determining the Etiology of Autism
Salvatore A. Currenti
CELLULAR AND MOLECULAR NEUROBIOLOGY (2010)
Double-blind placebo-controlled trial of pentoxifylline added to risperidone: Effects on aberrant behavior in children with autism
Shahin Akhondzadeh et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2010)
Double-blind, placebo-controlled trial of risperidone plus topiramate in children with autistic disorder
Vala Rezaei et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2010)
A systematic review of off-label uses of memantine for psychiatric disorders
Kristina Zdanys et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
Glutamate antagonists seem to be slightly effective in psychopharmacologic treatment of autism
Helmut Niederhofer
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2007)
Memantine as adjunctive therapy in children diagnosed with autistic spectrum disorders: An observation of initial clinical response and maintenance tolerability
Michael G. Chez et al.
JOURNAL OF CHILD NEUROLOGY (2007)
A retrospective study of memantine in children and adolescents with pervasive developmental disorders
Craig A. Erickson et al.
PSYCHOPHARMACOLOGY (2007)
Autism Spectrum Disorders: Etiology and Pharmacotherapy
Mohammad-Reza Mohammadi et al.
CURRENT DRUG THERAPY (2007)
A prospective, open-label trial of memantine in the treatment of cognitive, behavioral, and memory dysfunction in pervasive developmental disorders
Thomas Owley et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2006)
Glial fibrillary acidic protein is elevated in superior frontal, parietal and cerebellar cortices of autistic subjects
JA Laurence et al.
CEREBELLUM (2005)
Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial
S Akhondzadeh et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2004)
Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices
SH Fatemi et al.
BIOLOGICAL PSYCHIATRY (2002)
Share Paper
